Results for tag: "Arthralgia Drug"

The Arthralgia Drug market is a subset of the larger Musculoskeletal Disorders Drugs market. It is composed of drugs used to treat arthralgia, which is a type of joint pain. These drugs are typically used to reduce inflammation and pain, and can be administered orally, topically, or through injection. Commonly used drugs include non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and disease-modifying antirheumatic drugs (DMARDs). The Arthralgia Drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, Merck, Novartis, Sanofi, and AbbVie. Other companies include Bristol-Myers Squibb, Eli Lilly, and GlaxoSmithKline. Show Less Read more